In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

New Joint European Cardiovascular Prevention Guidelines launched today

Preventive Cardiology
Risk Factors and Prevention
Cardiovascular Nursing

 

Florence, Italy – 24 May 2016: New Joint European Cardiovascular Prevention Guidelines emphasising population approaches for the first time have been published in European Heart Journal,1 the European Journal of Preventive Cardiology and other specialty journals. 

The document gives the latest advice on prevention of cardiovascular disease (CVD) in individuals and populations and was launched at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure in Florence, Italy. Key messages will be presented at ESC Congress.

“The last 30 years have witnessed a decrease in deaths from CVD, mainly due to improved treatment of heart disease, and falls in cholesterol, blood pressure and smoking,” said Professor Massimo F. Piepoli, Chairperson of the guidelines Task Force. “This trend is partly offset by rising obesity and type 2 diabetes, and poor adherence to lifestyle changes.”

The document was written by the sixth joint Task Force of the European Society of Cardiology and nine other societies. It argues that CVD mortality rates could be halved by modest risk factor reduction. New scientific evidence has led to adapted target levels for important risk factors, such as blood pressure and lipids. Special attention has been dedicated to younger adults and to the elderly.

Reducing population risk by 1% would prevent 25 000 CVD cases and save €40 million per year in a single European country. Stronger laws and policies on food, physical activity and smoking are needed, such as:

Food

  • Legislate food composition to reduce calories, salt, saturated fat, sugar, and limit portion sizes
  • Eliminate industrially produced trans fats
  • Legislate to restrict marketing foods high in fat, sugar and salt to children
  • Tax foods rich in sugar and saturated fat, and alcoholic drinks
  • Make water and healthy food available in schools and workplaces
  • Regulate location and density of fast food outlets.

 

Physical activity

  • Consider physical activity when planning new landscaping, buildings or towns
  • Post signs to encourage use of stairs
  • Increase fuel taxes
  • Provide tax incentives to buy exercise equipment or gym membership
  • Give financial incentives to lose weight and increase fitness.

 

Smoking

  • Restrict advertising, marketing and sale of smokeless tobacco
  • Ban smoking in school, pre-school and child care to protect from passive smoking
  • Advise parents to be tobacco-free when children are present and never smoke in cars or at home
  • Give electronic cigarettes the same marketing restrictions as cigarettes.

 

The detrimental impact of air pollution on heart health is highlighted, and the authors say the media can inform the public about air quality (for example by using apps) and provide smog alerts. Air quality can be improved by reducing taxes on electrical and hybrid cars. New houses and schools should be built away from highways and polluting industries.

Professor Piepoli said: “A healthy environment is essential for preventing CVD. Lawmakers need to take more responsibility for their nation’s wellbeing by taxing unhealthy choices and incentivising healthy ones.”

Novel recommendations are given for patients with rheumatoid arthritis, erectile dysfunction, and patients receiving treatment for cancer. Women with a history of pre-eclampsia, premature birth, polycystic ovary syndrome or gestational diabetes should be screened for diabetes and hypertension. CVD risk varies considerably between immigrant groups and ethnicity should be considered in CVD risk assessment.

Professor Arno W. Hoes, Task Force Co-chairperson, said: “The recommendations cover the entire spectrum of CVD prevention in individuals and populations. We all have a role to play to stop heart disease.”

ENDS

References

References and notes

12016 European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2016;37(29):2315–2381. doi: 10.1093/eurheartj/ehw106

http://eurheartj.oxfordjournals.org/lookup/doi/10.1093/eurheartj/ehw106

 

Guidelines at ESC Congress

The Prevention Guidelines will be featured in:

 

Associated Derivative Products can be found via the ESC Website at:

http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Guidelines-derivative-products/esc-guidelines-derivative-products

Download the free ESC Pocket Guidelines App for all mobile devices: http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Guidelines-derivative-products/ESC-Mobile-Pocket-Guidelines

 

About the European Society of Cardiology

The European Society of Cardiology (ESC) represents more than 95 000 cardiology professionals across Europe and worldwide. Its mission is to reduce the burden of cardiovascular disease in Europe.

 

About ESC Congress 2016

ESC Congress is the world’s largest and most influential cardiovascular scientific conference contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2016 takes place 27 to 31 August at the Fiera di Roma in Rome, Italy. The scientific programme is here. More information is available from the ESC Press Office at press@escardio.org.

 

Notes to editor

SOURCES OF FUNDING: None.

 

DISCLOSURES: The disclosure forms of all experts involved in the development of these guidelines are available on the ESC website www.escardio.org/guidelines